Pasqal Heads Into Debut Print With Activist on the Register and Borrow Costs Near 300%
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Pasqal Holding SA (PSQL) reports its first earnings as a public company on September 24, entering the print with a uniquely charged ownership structure, extreme borrow costs, and fresh analyst coverage — all within weeks of listing.
The most newsworthy fact about PSQL right now is the presence of an activist on its 13D/G register. Bpifrance Participations S.A. filed a Schedule 13D on September 3, disclosing an 11.4% stake of roughly 24.5 million shares — the 13D designation signals active intent, not passive ownership. A second holder, Inflection Point Fund I, LP, filed a Schedule 13G the following day, reporting a 7.0% position. Together, the two holders account for nearly a fifth of outstanding shares. Readers should note the standard caveat: 13D/G positions are event-driven disclosures around the 5% threshold, and stakes are "as last disclosed" — holders dropping below 5% may exit without filing again.
The borrow market tells its own story about how hard it is to bet against this stock. Cost to borrow has run near 300% for most of September — briefly hitting 342% in early September before easing slightly to 296% on the most recent reading. That level is extreme by any measure. Yet despite those punishing costs, availability has actually loosened sharply over the past week, rising 73% to 231% of estimated short interest, well above its 52-week tightest reading of 89%. That combination — very expensive to borrow, but more shares now technically available — reflects a lending market in flux around the debut print rather than a building short squeeze. The stock itself has pulled back hard, falling 24% over the past month to $7.40, though it bounced 1.2% on the most recent session.
Two initiations landed in the two weeks before the print, both bullish. Canaccord Genuity initiated on September 22 with a Buy and a $16 target; Roth Capital initiated on September 9 with a Buy and a $20 target. The consensus mean target of $15.58 implies more than 100% upside from the current price — a wide gap that reflects the speculative nature of early-stage quantum computing as much as conviction about near-term financials. ORTEX's own stock score for PSQL stands at 82.1, with a growth sub-score of 97.2 — exceptional for a company this early in its life. Value, predictably, scores just 28.3. The European Innovation Council Fund is the only institutional holder on record, with a 6.8% stake reported in late August.
Tomorrow's print is less about proving profitability and more about whether Pasqal can demonstrate the operational trajectory — revenue ramp, cash burn management, and hardware milestones — that justifies fresh analyst Buy ratings at targets more than double the current market price.
Stocks in this article
See the live data behind this article on ORTEX.
Open PSQL on ORTEX →How this article was generated
- Generated
- 23 Sept 2026, 04:05
- Data as of
- 23 Sept 2026, 04:00
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationEarningsAnalyst consensusInstitutional positioningRecent ORTEX notes
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.